enzyme is reduced below its threshold activity. This threshold effect is a function of the apparent excess 58 enzyme activity above pathway capacity. To evaluate the threshold and excess capacity of a single step in 59 OXPHOS, it is necessary not only to quantify the changes in enzyme activity, but determine the impact of 60 these changes on respiratory capacity through mt-pathways representative of physiological conditions [13] .
61
Respiration in the mammalian heart is supported by carbohydrates (10 to 40% [14] ) and fatty acids 
65
Conventional protocols in bioenergetics use either NADH-linked substrates (N) or succinate&rotenone (S), 66 thereby separating the system into linear thermodynamic cascades, forming distinct electron transfer chains 67 [17, 18] . This experimental design aims at the measurement of biochemical coupling efficiency and proton 68 stoichiometry, and is applied in the functional diagnosis of specific OXPHOS defects. 
88
Coupling of the phosphorylation system with the ETS allows the proton potential to drive phosphorylation 89 of ADP to ATP (coupled flow). Protonophores such as FCCP uncouple the ETS from ATP production. 
103
The aim of the present study is to quantify respiratory capacity of mouse heart mitochondria when 104 providing reducing equivalents simultaneously from the N-pathway ( 
Results

131
Pathway Control of Mitochondrial Respiratory Capacity
132
We quantified mitochondrial respiratory capacity in substrate-uncoupler-inhibitor-titration (SUIT) 133 protocols (Fig 1 and 2 (PGMP) by a factor of 2.5 (2.0-3.7) at 37 ºC (Fig 2A, B) . In contrast, addition of G to PM exerted merely a 137 slight stimulatory effect on respiration by a factor of 1.1 (1.0-1.2; Fig 2B) , also observed in rat heart (1 
259
In physiological states with simultaneous NS-electron flow, the apparent excess capacity of downstream 260 electron transfer is lower and flux control is shifted towards CIII and CIV. We therefore examined the 261 apparent excess capacity of CIV at maximum convergent pathway flux through the ETS. Azide titrations 262 resulted in hyperbolic inhibition of CIV (Fig 5A-E) . The threshold plots display NS-pathway flux as a 263 function of CIV activity (Fig 5F-J) . The two distinct phases are related to (1) the elimination of excess 
314
The phosphorylation system represents another functional unit potentially contributing to the 315 limitation of OXPHOS capacity, P, relative to ETS capacity, E. The extent of this limitation, E-P, is 316 expressed by the excess E-P capacity factor, jExP = (E-P)/E = 1-P/E, ranging from zero (no limitation) to 
423
The contents of the chambers were removed at the end of each experimental run and the chamber 424 was rinsed twice with 500 μl of respiration medium. 
